Valeant completes Salix Pharmaceuticals acquisition

Valeant Pharmaceuticals International has completed the acquisition of Salix Pharmaceuticals.

Advertisement
Carrie Pallardy

Salix Pharmaceuticals focuses on the gastroenterology market. The company offers treatments such as XIFAXAN, RUCONEST, APRISO, UCERIS and RELISTOR.

More articles on gastroenterology:
5 most-read GI articles – March 23 to March 27
4 recent GI market updates to know
18 statistics on gastroenterologist habits & burnout

A guide for evaluating the impact of ambient AI on clinicians

Recommended Whitepaper

Advertisement

Next Up in GI & Endoscopy

  • Is high acuity the new normal in GI?

    As colonoscopy demand rises, driven in part by more diagnostic referrals for patients under 55, GI leaders are also seeing…

    By: Patsy Newitt

  • ConMed to end its GI product lines

    Medical device company and surgical equipment manufacturer ConMed plans to exit its gastroenterology product lines.  ConMed’s gastroenterology segment is projected…

    By: Cameron Cortigiano
Advertisement

Comments are closed.